| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.78B | 37.56B | 36.35B | 36.06B | 35.45B | 35.98B |
| Gross Profit | 14.82B | 18.43B | 18.23B | 18.15B | 17.73B | 16.80B |
| EBITDA | 12.05B | 11.22B | 13.21B | 12.38B | 11.86B | 11.11B |
| Net Income | -168.00M | -66.00M | -471.00M | 393.00M | 1.26B | -1.02B |
Balance Sheet | ||||||
| Total Assets | 101.17B | 98.76B | 94.56B | 95.06B | 94.22B | 97.84B |
| Cash, Cash Equivalents and Short-Term Investments | 3.14B | 2.58B | 2.71B | 3.13B | 5.04B | 4.62B |
| Total Debt | 59.25B | 53.94B | 54.19B | 51.65B | 49.22B | 60.56B |
| Total Liabilities | 93.77B | 87.24B | 84.86B | 82.30B | 78.74B | 84.28B |
| Stockholders Equity | 4.23B | 7.49B | 2.48B | 11.44B | 14.36B | 9.93B |
Cash Flow | ||||||
| Free Cash Flow | 6.51B | 3.08B | 5.32B | 3.43B | 1.78B | 5.57B |
| Operating Cash Flow | 8.68B | 10.63B | 13.35B | 10.34B | 9.70B | 12.70B |
| Investing Cash Flow | -2.33B | -7.70B | -7.46B | -6.01B | -7.62B | -7.54B |
| Financing Cash Flow | -6.50B | -3.26B | -6.27B | -5.83B | -1.57B | -6.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$5.22B | 10.90 | 9.18% | 6.75% | 0.52% | 2.07% | |
76 Outperform | €649.91B | 13.81 | 7.66% | 5.13% | 0.53% | 5.28% | |
73 Outperform | $9.33B | 10.18 | 8.67% | 7.37% | -0.62% | -5.10% | |
72 Outperform | $87.02B | 16.89 | 14.75% | 2.89% | 2.33% | 2.41% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | HK$11.00B | 49.67 | 8.55% | 4.69% | 4.48% | 1820.51% | |
49 Neutral | HK$42.86B | -151.37 | ― | 1.65% | 4.26% | 36.68% |
PCCW Limited has renewed its service agreements with Lenovo Group, extending their collaboration until August 2028. This renewal involves continuing connected transactions under the 2025 Extended TSA and 2025 Services Agreement, allowing Lenovo PCCW Solutions to provide services to PCCW subsidiaries. These agreements are on normal commercial terms and exempt from certain regulatory requirements, ensuring seamless continuation of operations and strengthening PCCW’s market position.
The most recent analyst rating on (HK:0008) stock is a Buy with a HK$5.00 price target. To see the full list of analyst forecasts on PCCW Limited stock, see the HK:0008 Stock Forecast page.